- Report
- August 2025
- 181 Pages
Global
From €3450EUR$3,939USD£2,994GBP
The Long Acting Analgesic market is a subset of the Analgesic market, which includes drugs used to relieve pain. Long Acting Analgesics are drugs that provide pain relief for a longer period of time than traditional Analgesics. These drugs are typically used to treat chronic pain, such as that caused by arthritis, cancer, and other long-term conditions. Long Acting Analgesics are typically administered orally, intramuscularly, or intravenously.
Some of the companies in the Long Acting Analgesic market include Pfizer, Merck, Novartis, and Johnson & Johnson. These companies produce a variety of Long Acting Analgesics, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and other drugs. Show Less Read more